IP Library Granted Patent US 7,592,149
Granted Patent B2
US 7,592,149 · App. 11/368,284 · Granted Sep 22, 2009

Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,592,149
App. No.
11/368,284
Granted
Sep 22, 2009
Kind
B2
Abstract

A novel gene (designated 184P1E2) and its encoded protein, and variants thereof, are described wherein 184P1E2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 184P1E2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 184P1E2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization.

Claims (10)

1. An isolated polynucleotide which has the nucleic acid sequence of SEQ ID NO:4.

2. The polynucleotide of claim 1 which has the nucleic acid sequence comprising residues 42 to 2036 of SEQ ID NO:4.

3. A viral vector that comprises the polynucleotide of claim 1 .

4. A viral vector that comprises the polynucleotide of claim 2 .

5. The viral vector of claim 3 comprising a viral gene delivery system selected from the group consisting of vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, and sindbis virus.

6. The viral vector of claim 4 comprising a viral gene delivery system selected from the group consisting of vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, and sindbis virus.

7. An isolated host cell that contains the vector of claim 3 .

8. An isolated host cell that contains the vector of claim 4 .

9. A process for producing a protein having the sequence encoded by SEQ ID NO:4, comprising culturing a host cell of claim 7 under conditions sufficient for the production of the protein, and recovering the protein from the culture.

10. A process for producing a protein having the sequence encoded by SEQ ID NO:4, comprising culturing a host cell of claim 8 under conditions sufficient for the production of the protein, and recovering the protein from the culture.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2006
From: CHALLITA-EID, PIA M.; RAITANO, ARTHUR B.; FARIS, MARY; HUBERT, RENE S.; MORRISON, KAREN JANE MEYRICK; MORRISON, ROBERT KENDALL; GE, WANGMAO; JAKOBOVITZ, AYA
To: AGENSYS, INC.
Reel/Frame 017573/0276 →